US Acne & Rosacea Market: Insights, Trends & Forecast (2020-2024)

Publisher Name :
Date: 03-Aug-2020
No. of pages: 133
Inquire Before Buying

The US acne market is expected to reach US$4.49 billion in 2024, recording growth at a CAGR of 4.12% during the period spanning 2019-2024. The US rosacea market is expected to reach US$1.80 billion in 2024, growing at a CAGR of 5.92% during the period spanning 2019-2024. Growth in the acne and rosacea market has accrued due to the rising youth population, increasing purchasing power of the consumers and escalating healthcare expenditure. The market is anticipated to experience certain trends like growing awareness about acne & rosacea and their treatments and increasing importance of personal appearance. The US acne & rosacea market would face challenges regarding entry of generic drugs and side effects of therapies.

The US acne market by drug type can be segmented as follows: topical drugs and oral antibiotics. In 2019, the higher share of the market was held by topical drugs, followed by oral antibiotics. The US acne topical drugs by brand can be segmented into the following: Epiduo Franchise, Aczone Franchise, Retin-A-Franchise, Onextin/Acanya and Veltin. In 2019, the dominant share was held by Epiduo Franchise, followed by Aczone Franchise. The US acne oral antibiotics by brand can be segmented as follows: Solodyn, Acticlate, Doryx Franchise and Targadox. The highest share of the market was held by Solodyn, followed by Acticlate and Doryx Franchise. The US acne addressable population by severity can be segmented as follows: moderate patients, mild patients and severe patients. The largest share of market was held by moderate patients.

The US rosacea market by drug type can be segmented as follows: topical drugs and oral antibiotics. The dominant share of the market was held by topical drugs segment in 2019. The US rosacea drug revenue by brand can be segmented into following: Metrogel, Oracea, Soolantra, Finacea, Vasoconstrictors and Minocycline. In 2019, the dominant share of the revenue was generated by Metrogel, followed by Oracea.

Scope of the report:


  • The report provides a comprehensive analysis of the US acne & rosacea market.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Allergan, Bausch Health Companies, Leo Pharma, Sol Gel Technologies, Foamix Pharmaceuticals & Galderma) are also presented in detail.


Key Target Audience:


  • Hospitals/Acne & Rosacea Drug Suppliers

  • API Suppliers

  • End Users (Businesses/Consumers)

  • Investment Banks

  • Government Bodies & Regulating Authorities

US Acne & Rosacea Market: Insights, Trends & Forecast (2020-2024)

Table of Contents

1. Market Overview
1.1 Acne
1.1.1 Acne Overview
1.1.2 Causes & Symptoms of Acne
1.1.3 Classification of Severity
1.1.4 Treatment for Acne
1.1.5 Acne Treatment Continuum
1.1.6 Limitations of Acne Treatments
1.2 Rosacea
1.2.1 Rosacea Overview
1.2.2 Symptoms and Causes of Rosacea
1.2.3 Treatment for Rosacea

2. The US Acne Market
2.1 The US Acne Market Forecast by Value
2.2 The US Acne Market by Drug Type
2.3 The US Acne Topical Drugs by Brand
2.4 The US Acne Oral Antibiotics by Brand
2.5 The US Acne Market Forecast by Product
2.5.1 The US Minocycline Revenue Forecast
2.5.2 The US Retin-A Generics Revenue Forecast
2.5.3 The US Epiduo/Epiduo Forte Revenue Forecast
2.5.4 The US Aczone Revenue Forecast
2.5.5 The US Onexton Revenue Forecast
2.5.6 The US Solodyne Revenue Forecast
2.5.7 The US Oracea Revenue Forecast
2.5.8 The US Ziana Revenue Forecast
2.6 The US Acne Prevalence Forecast
2.7 The US Acne Addressable Population
2.7.1 The US Acne Addressable Population Forecast
2.7.2 The US Acne Addressable Population by Severity
2.7.3 The US Moderate Acne Population Forecast
2.7.4 The US Mild Acne Population Forecast
2.7.5 The US Severe Acne Population Forecast
2.8 The US Acne Topical Treatment Population
2.8.1 The US Acne Topical Treatment Population Forecast
2.8.2 The US Acne Topical Treatment Population by Severity
2.8.3 The US Acne Topical Treatment Moderate Population Forecast
2.8.4 The US Acne Topical Treatment Moderate Population Forecast
2.8.5 The US Severe Acne Topical Treatment Population Forecast
2.9 FMX101
2.9.1 The US FMX-101 Drug Market Share Forecast
2.9.2 The US FMX-101 Drug Cost Forecast
2.9.3 The US FMX-101 Drug Revenue Forecast
2.10 TWIN
2.10.1 The US TWIN Drug Patient Population Forecast
2.10.2 The US TWIN Drug Market Share Forecast
2.10.3 The US TWIN Drug Cost Forecast
2.10.4 The US TWIN Drug Revenue Forecast
2.11 SIRS-T
2.11.1 The US SIRS-T Drug Patient Population Forecast
2.11.2 The US SIRS-T Drug Market Share Forecast
2.11.3 The US SIRS-T Drug Cost Forecast
2.11.4 The US SIRS-T Drug Revenue Forecast

3. The US Rosacea Market
3.1 The US Rosacea Market Forecast by Value
3.2 The US Rosacea Total Cases Forecast
3.3 The US Rosacea Market by Drug Type
3.3.1 The US Rosacea Market Revenue and Prescription by Brand
3.4 The US Rosacea Prevalence Forecast
3.5 The US Rosacea Addressable Population
3.5.1 The US Rosacea Addressable Population Forecast
3.5.2 The US Rosacea Addressable Population by Severity
3.5.3 The US Mild Rosacea Population Forecast
3.5.4 The US Moderate Rosacea Population Forecast
3.5.5 The US Severe Rosacea Population Forecast
3.6 The US Rosacea Topical Treatment Population
3.6.1 The US Rosacea Topical Treatment Population Forecast
3.6.2 The US Rosacea Topical Treatment Population by Severity
3.6.3 The US Moderate Rosacea Topical Treatment Population Forecast
3.6.4 The US Mild Rosacea Topical Treatment Population Forecast
3.6.5 The US Severe Rosacea Topical Treatment Population Forecast
3.7 FMX103
3.7.1 The US FMX-103 Drug Market Share Forecast
3.7.2 The US FMX-103 Drug Revenue Forecast
3.8 VERED
3.8.1 The US VERED Drug Patient Population Forecast
3.8.2 The US VERED Drug Market Share Forecast
3.8.3 The US VERED Drug Cost Forecast
3.8.4 The US VERED Drug Revenue Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Youth Population
4.1.2 Rising Purchasing Power
4.1.3 Escalating Healthcare Expenditure
4.1.4 Vast Market Opportunity
4.1.5 Sedentary Lifestyle and Unhealthy Eating Habits
4.2 Key Trends & Developments
4.2.1 Growing Awareness
4.2.2 Increasing Medical Tourism
4.2.3 Preference for Minimally Invasive Procedures
4.2.4 Importance of Personal Appearance
4.3 Challenges
4.3.1 Entry of Generic Drugs
4.3.2 Side Effects of Acne and Rosacea Therapies
4.3.3 Tough Regulations

5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue Comparison – Key Players
5.1.2 Market Capitalization Comparison – Key Players
5.1.3 Research & Development Comparison – Key Players
5.1.4 Global Acne Market- Drug Comparison by Company
5.1.5 Global Late Stage Acne Market- Drug Comparison by Company
5.1.6 Global Mid Stage Acne Market- Drug Comparison by Company
5.1.7 Global Rosacea Market- Drug Comparison by Company

6. Company Profiles
6.1 Bausch Health Companies, Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Foamix Pharmaceuticals Ltd.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Allergan Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Sol Gel Technologies Ltd.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Galderma
6.5.1 Business Overview
6.5.2 Business Strategies
6.6 Leo Pharma
6.6.1 Business Overview
6.6.2 Financial Overview
6.6.3 Business Strategies

List of Charts

Types of Acne
Treatment for Acne
Types of Rosacea
Treatment for Rosacea
The US Acne Market Forecast by Value (2019-2024)
The US Acne Market by Drug Type (2019)
The US Acne Topical Drugs by Brand (2019)
The US Acne Oral Antibiotics by Brand (2019)
The US Minocycline Revenue Forecast (2019-2024)
The US Retin-A Generics Revenue Forecast (2019-2024)
The US Epiduo/Epiduo Forte Revenue Forecast (2019-2024)
The US Aczone Revenue Forecast (2019-2024)
The US Onexton Revenue Forecast (2019-2024)
The US Solodyne Revenue Forecast (2019-2024)
The US Oracea Revenue Forecast (2019-2024)
The US Ziana Revenue Forecast (2019-2024)
The US Acne Prevalence Forecast (2019-2024)
The US Acne Addressable Population Forecast (2019-2024)
The US Acne Addressable Population by Severity (2019)
The US Moderate Acne Population Forecast (2019-2024)
The US Mild Acne Population Forecast (2019-2024)
The US Severe Acne Population Forecast (2019-2024)
The US Acne Topical Treatment Population Forecast (2019-2024)
The US Acne Topical Treatment Population by Severity (2019)
The US Acne Topical Treatment Moderate Population Forecast (2019-2024)
The US Acne Topical Treatment Mild Population Forecast (2019-2024)
The US Severe Acne Topical Treatment Population Forecast (2019-2024)
The US FMX-101 Drug Market Share Forecast (2020-2024)
The US FMX-101 Drug Cost Forecast (2020-2024)
The US FMX-101 Drug Revenue Forecast (2020-2024)
The US TWIN Drug Patient Population Forecast (2021-2025)
The US TWIN Drug Market Share Forecast (2021-2025)
The US TWIN Drug Cost Forecast (2021-2025)
The US TWIN Drug Revenue Forecast (2021-2025)
The US SIRS-T Drug Patient Population Forecast (2022-2026)
The US SIRS-T Drug Market Share Forecast (2022-2026)
The US SIRS-T Drug Cost Forecast (2022-2026)
The US SIRS-T Drug Revenue Forecast (2022-2026)
The US Rosacea Market Forecast by Value (2019-2024)
The US Rosacea Total Cases Forecast (2019-2024)
The US Rosacea Market by Drug Type (2019)
The US Rosacea Drug Revenue Share by Brand (2019)
The US Rosacea Prevalence Forecast (2019-2024)
The US Rosacea Addressable Population Forecast (2019-2024)
The US Rosacea Addressable Population by Severity (2019)
The US Mild Rosacea Population Forecast (2019-2024)
The US Moderate Rosacea Population Forecast (2019-2024)
The US Severe Rosacea Population Forecast (2019-2024)
The US Rosacea Topical Treatment Population Forecast (2019-2024)
The US Rosacea Topical Treatment Population by Severity (2019)
The US Moderate Rosacea Topical Treatment Population Forecast (2019-2024)
The US Mild Rosacea Topical Treatment Population Forecast (2019-2024)
The US Severe Rosacea Topical Treatment Population Forecast (2019-2024)
The US FMX-103 Drug Market Share Forecast (2021-2025)
The US FMX-103 Drug Revenue Forecast (2021-2025)
The US VERED Drug Patient Population Forecast (2021-2025)
The US VERED Drug Market Share Forecast (2021-2025)
The US VERED Drug Cost Forecast (2021-2025)
The US VERED Drug Revenue Forecast (2021-2025)
The US Youth Population (2019)
The US GNI Per Capita (2015-2019)
The US Healthcare Expenditure (2016-2024)
The US Dermatology Drugs Market (2014-2019)
Bausch Health Companies Revenue and Net Income (Loss) (2015-2019)
Bausch Health Companies Revenue by Segment (2019)
Bausch Health Companies Revenue by Region (2019)
Foamix Pharmaceuticals Revenue and Net Loss (2015-2019)
Allergan Net Revenue and Net Loss (2015-2019)
Allergan Net Revenue by Segment (2019)
Allergan Net Revenue by Region (2019)
Sol Gel Technologies Ltd. Revenue and Loss (2015-2019)
Leo Pharma Revenue and Net Profit (Loss) (2015-2019)
Leo Pharma Revenue by Segment (2019)
Leo Pharma Revenue by Region (2019)

List of Tables

Acne Treatment Continuum
Limitations of Commonly Used Acne Treatments
Key Players - Revenue Comparison (2019)
Key Players - Market Capitalization Comparison (2019)
Key Players – Research & Development Comparison (2019)
Global Acne Market- Drug Comparison by Company (2019)
Global Late Stage Acne Market- Drug Comparison by Company (2019)
Global Mid Stage Acne Market- Drug Comparison by Company (2019)
Global Rosacea Market- Drug Comparison by Company (2019)

  • Global Lip Balm Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 148
    According to our LPI (LP Information) latest study, the global Lip Balm market size was valued at US$ 821.8 million in 2023. With growing demand in downstream market, the Lip Balm is forecast to a readjusted size of US$ 1245.6 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Lip Balm market. Lip Balm are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Professional Skincare Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Professional Skincare market size was valued at US$ 11820 million in 2023. With growing demand in downstream market, the Professional Skincare is forecast to a readjusted size of US$ 14850 million by 2030 with a CAGR of 3.3% during review period. The research report highlights the growth potential of the global Professional Skincare market. Professional Skincare are expected to show stable growth in the future market. However......
  • Global Professional Skincare Products Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Professional Skincare Products market size was valued at US$ 11820 million in 2023. With growing demand in downstream market, the Professional Skincare Products is forecast to a readjusted size of US$ 14850 million by 2030 with a CAGR of 3.3% during review period. The research report highlights the growth potential of the global Professional Skincare Products market. Professional Skincare Products are expected to show stable ......
  • Global Body Lotion Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Body Lotion market size was valued at US$ 15030 million in 2023. With growing demand in downstream market, the Body Lotion is forecast to a readjusted size of US$ 21260 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Body Lotion market. Body Lotion are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Professional Skin Care Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Professional Skin Care market size was valued at US$ 11820 million in 2023. With growing demand in downstream market, the Professional Skin Care is forecast to a readjusted size of US$ 14850 million by 2030 with a CAGR of 3.3% during review period. The research report highlights the growth potential of the global Professional Skin Care market. Professional Skin Care are expected to show stable growth in the future market. How......
  • Global Anti-Aging Products and Therapies Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 105
    According to our LPI (LP Information) latest study, the global Anti-Aging Products and Therapies market size was valued at US$ 13320 million in 2023. With growing demand in downstream market, the Anti-Aging Products and Therapies is forecast to a readjusted size of US$ 28950 million by 2030 with a CAGR of 11.7% during review period. The research report highlights the growth potential of the global Anti-Aging Products and Therapies market. Anti-Aging Products and Therapies are expected to......
  • Global Night Skin Care Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Night Skin Care Products market: According to our latest research, the global Night Skin Care Products market looks promising in the next 5 years. As of 2022, the global Night Skin Care Products market was estimated at USD 41722.93 million, and it's anticipated to reach USD 57327.71 million in 2028, with a CAGR of 5.44% during the forecast years. At night, under the surface of the skin, the cells are undergoing recovery, regeneration and reconstructi......
  • Global Facial Water Spray Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 133
    According to our LPI (LP Information) latest study, the global Facial Water Spray market size was valued at US$ 1513.4 million in 2023. With growing demand in downstream market, the Facial Water Spray is forecast to a readjusted size of US$ 2472 million by 2030 with a CAGR of 7.3% during review period. The research report highlights the growth potential of the global Facial Water Spray market. Facial Water Spray are expected to show stable growth in the future market. However, product di......
  • Global Anti Acne Cleanser Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Anti Acne Cleanser market size was valued at US$ 976.3 million in 2023. With growing demand in downstream market, the Anti Acne Cleanser is forecast to a readjusted size of US$ 1127.2 million by 2030 with a CAGR of 2.1% during review period. The research report highlights the growth potential of the global Anti Acne Cleanser market. Anti Acne Cleanser are expected to show stable growth in the future market. However, product d......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs